Trial Profile
An 8-week, Prospective, Interventional, Single-arm, Multi-centre, Phase IV Study to Evaluate the Efficacy and Safety of Controlled-release Oxycodone/Naloxone (Targin) in Moderate to Severe Low Back Pain Patients Who Are Not Adequately Controlled by NSAIDs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jan 2021
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Mundipharma International
- 21 Jan 2021 Status changed from active, no longer recruiting to completed.
- 17 Apr 2020 Planned End Date changed from 1 Apr 2020 to 1 Oct 2020.
- 17 Apr 2020 Status changed from recruiting to active, no longer recruiting.